- Home
- OST vs RNXT Comparison
OST vs RNXT Comparison
Compare OST & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- RNXT
- Stock Information
- Founded
- OST 2010
- RNXT 2012
- Country
- OST China
- RNXT United States
- Employees
- OST N/A
- RNXT N/A
- Industry
- OST Industrial Machinery/Components
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- RNXT Health Care
- Exchange
- OST Nasdaq
- RNXT Nasdaq
- Market Cap
- OST 51.0M
- RNXT 44.6M
- IPO Year
- OST 2022
- RNXT 2021
- Fundamental
- Price
- OST $5.51
- RNXT $1.40
- Analyst Decision
- OST
- RNXT Strong Buy
- Analyst Count
- OST 0
- RNXT 2
- Target Price
- OST N/A
- RNXT $7.00
- AVG Volume (30 Days)
- OST 1.9M
- RNXT 210.6K
- Earning Date
- OST 01-27-2025
- RNXT 05-15-2025
- Dividend Yield
- OST N/A
- RNXT N/A
- EPS Growth
- OST N/A
- RNXT N/A
- EPS
- OST N/A
- RNXT N/A
- Revenue
- OST $32,463,213.00
- RNXT $240,000.00
- Revenue This Year
- OST N/A
- RNXT $3,927.91
- Revenue Next Year
- OST N/A
- RNXT $219.75
- P/E Ratio
- OST N/A
- RNXT N/A
- Revenue Growth
- OST N/A
- RNXT N/A
- 52 Week Low
- OST $0.78
- RNXT $0.75
- 52 Week High
- OST $5.60
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- OST 79.35
- RNXT 78.13
- Support Level
- OST $4.00
- RNXT $1.17
- Resistance Level
- OST $4.84
- RNXT $1.30
- Average True Range (ATR)
- OST 0.33
- RNXT 0.08
- MACD
- OST 0.04
- RNXT 0.02
- Stochastic Oscillator
- OST 94.38
- RNXT 100.00
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.